A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 12, 2007

Primary Completion Date

August 19, 2008

Study Completion Date

August 19, 2008

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

pregabalin

Dosage: 150-600 mg/day (75-300 mg bid), oral administration, Treatment duration: 52 weeks

Trial Locations (33)

460-0001

National Hospital Organization Nagoya Medical Center, Nagoya

279-0012

Kobayashi Clinic, Urayasu

811-2122

Okabe Hospital, Kasuya-gun

379-2147

Gunma Pain Clinic Hospital, Maebashi

370-0035

Takasaki Pain Clinic, Takasaki

070-0034

Asahikawa Pain Clinic Hospital, Asahikawa

070-8013

Kamui Pain Clinic, Asahikawa

001-0045

Sapporo Asabu Clinic, Sapporo

003-8585

Higashi Sapporo Hospital, Sapporo

673-0016

Seimei Clinic, Akashi

661-0012

Uchida Pain Relief Clinic, Amagasaki

670-8520

National Hospital Organization Himeji Medical Center, Himeji

654-0155

National Hospital Organization Kobe Medical Center, Kobe

655-0854

Nakamura Clinic, Kobe

228-8522

National Hospital Organization Sagamihara National Hospital, Sagamihara

227-0043

Suzuki Pain Clinic, Yokohama

236-0037

Hajiri Pain Clinic, Yokohama

245-8575

National Hospital Organization Yokohama Medical Center, Yokohama

983-0036

Sendai Pain Clinic, Sendai

874-0937

Nakamura Hospital, Beppu

332-0031

Kawaguchi Kogyo General Hospital, Kawaguchi

359-0038

Kinoshita Clinic, Tokorozawa

116-8567

Tokyo Women's Medical University Center East, Arakawa-ku

113-8431

Juntendo University Hospital, Bunkyo-ku

181-0013

Mitaka Pain Clinic, Mitaka

165-0027

Toriumi Pain Clinic, Nakano-ku

141-0022

Kanto Medical NTT East Corporation, Shinagawa-ku

Naganuma Pain Clinic, Shinagawa-ku

162-8666

Tokyo Women's Medical University Hospital, Shinjuku-ku

812-0011

Mukai Clinic, Fukuoka

814-0001

KM Pain Clinic, Fukuoka

960-8044

Otsuki Sleep Clinic, Fukushima

330-0805

Hasumi Pain Clinic, Saitama

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00424372 - A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia | Biotech Hunter | Biotech Hunter